pmc Br J Cancer Br J Cancer 334 brjcancer 0370635 British Journal of Cancer 0007-0920 1532-1827 Nature Publishing Group PMC2361379 PMC2361379.1 2361379 2361379 16508630 10.1038/sj.bjc.6603028 6603028 1 Clinical Study Metallothionein – overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients Metallothionein overexpresssion in melanoma Weinlich G 1 * Eisendle K 1 Hassler E 1 Baltaci M 1 Fritsch P O 1 Zelger B 1 1 Clinical Department of Dermatology and Venerology, Innsbruck Medical University, Anichstrasse 35, Innsbruck A-6020, Austria * Clinical Department of Dermatology and Venerology, Innsbruck Medical University, Anichstrasse 35, Innsbruck A-6020, Austria.
← all excerpts
Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients.
1
—
—